Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Artur Beltrame Ribeiro. (2006) Angiotensin II antagonists – therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy. Current Medical Research and Opinion 22:1, pages 1-16.
Read now
Read now
Egbert H. E. Biesheuvel & Ludwig A. Hothorn. (2003) Protocol Designed Subgroup Analyses in Multiarmed Clinical Trials: Multiplicity Aspects. Journal of Biopharmaceutical Statistics 13:4, pages 663-673.
Read now
Read now
Luis Ruilope & Bodo Jager. (2003) Eprosartan for the treatment of hypertension. Expert Opinion on Pharmacotherapy 4:1, pages 107-114.
Read now
Read now
Roberto J.S. Franco, Suely Goldflus, Mari Mcquitty & Wille Oigman. (2003) Efficacy and tolerability of the combination valsartan/hydrochlorothiazide compared with amlodipine in a mild‐to‐moderately hypertensive Brazilian population. Blood Pressure 12:sup2, pages 41-47.
Read now
Read now
Articles from other publishers (17)
Benjamin J. Powers, Remy R. Coeytaux, Rowena J. Dolor, Vic Hasselblad, Uptal D. Patel, William S. YancyJr.Jr., Rebecca N. Gray, R. Julian Irvine, Amy S. Kendrick & Gillian D. Sanders. (2011) Updated Report on Comparative Effectiveness of ACE inhibitors, ARBs, and Direct Renin Inhibitors for Patients with Essential Hypertension: Much More Data, Little New Information. Journal of General Internal Medicine 27:6, pages 716-729.
Crossref
Crossref
Thomas D. Giles, Suzanne Oparil, Antonia Wang & Robert Dubiel. (2009) An evaluation of the efficacy of olmesartan medoxomil in Black patients with hypertension. Journal of the American Society of Hypertension 3:6, pages 395-402.
Crossref
Crossref
Artur Beltrame Ribeiro & Haralambos Gavras. (2006) Angiotensin II antagonists: clinical experience in the treatment of hypertension, prevention of cardiovascular outcomes and renal protection in diabetic nephropathy and proteinuria. Arquivos Brasileiros de Endocrinologia & Metabologia 50:2, pages 327-333.
Crossref
Crossref
Elizabeth O. Ofili. (2006) Dispelling the Myth of "Aggressive" Antihypertensive Therapy. The Journal of Clinical Hypertension 8:s1, pages 4-11.
Crossref
Crossref
L. Alcocer, P. Fernandez-Bonetti, E. Campos, R. Dominguez-Henkel, J.J. DE La Fuente & C. Segovia-Ayala. (2004) Clinical efficacy and safety of telmisartan 80 mg once daily compared with enalapril 20 mg once daily in patients with mild-to-moderate hypertension: results of a multicentre study. International Journal of Clinical Practice 58, pages 23-28.
Crossref
Crossref
Massimo Volpe. (2004) Hypertension therapy: Mixing, matching, and meeting targets. Advances in Therapy 21:2, pages 107-122.
Crossref
Crossref
Thomas Unger & Bernward A. SchölkensM. de Gasparo. 2004. Angiotensin Vol. II. Angiotensin Vol. II
417
451
.
N. V. Lebedeva, N. M. Chikhladze, L. A. Belova, G. N. Litonova, A. N. Strozhilova & G. V. Ignashenkova. (2003) Efficacy of the ATl-angiotensin receptor blocker eprosartan in patients with arterial hypertension in the different functional state of the renin-angiotensin-aldesterone system. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 9:1, pages 17-20.
Crossref
Crossref
Y Lacourcière. (2016) A New Fixed-Dose Combination for Added Blood Pressure Control: Telmisartan Plus Hydrochlorothiazide. Journal of International Medical Research 30:4, pages 366-379.
Crossref
Crossref
Andrew Fenves & C. Venkata S. Ram. (2002) Are angiotensin converting enzyme inhibitors and angiotensin receptor blockers becoming the treatment of choice in African-Americans?. Current Hypertension Reports 4:4, pages 286-289.
Crossref
Crossref
Angela Cheng-Lai. (2002) Eprosartan. Heart Disease, pages 54-59.
Crossref
Crossref
E Breeze, EC Rake, MD Donoghue & AE Fletcher. (2001) Comparison of quality of life and cough on eprosartan and enalapril in people with moderate hypertension. Journal of Human Hypertension 15:12, pages 857-862.
Crossref
Crossref
Norman K. Hollenberg. (2001) Potential of the angiotensin II receptor 1 blocker eprosartan in the management of patients with hypertension or heart failure. Current Hypertension Reports 3:1, pages S25-S28.
Crossref
Crossref
Janet B. Mcgill & Paul A. Reilly. (2009) Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension. Clinical Cardiology 24:1, pages 66-72.
Crossref
Crossref
Neil H. Shusterman. (1999) Safety and efficacy of eprosartan, a new angiotensin II receptor blocker. American Heart Journal 138:3, pages S238-S245.
Crossref
Crossref
Michael Weber. (2012) Clinical Efficacy of Eprosartan. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 19:4P2.
Crossref
Crossref
Irene Gavras & Haralambos Gavras. (2012) Safety and Tolerability of Eprosartan. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 19:4P2.
Crossref
Crossref